PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 34 filers reported holding PROTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $58 | -98.1% | 22 | -97.0% | 0.00% | – |
| Q1 2022 | $3,000 | -93.6% | 745 | -89.2% | 0.00% | – |
| Q4 2021 | $47,000 | +1466.7% | 6,878 | +1217.6% | 0.00% | – |
| Q3 2021 | $3,000 | -66.7% | 522 | -44.0% | 0.00% | – |
| Q2 2021 | $9,000 | -86.2% | 932 | -77.3% | 0.00% | – |
| Q1 2021 | $65,000 | +16.1% | 4,100 | +76.1% | 0.00% | – |
| Q4 2020 | $56,000 | +86.7% | 2,328 | +30.9% | 0.00% | – |
| Q3 2020 | $30,000 | -71.2% | 1,778 | -49.7% | 0.00% | – |
| Q2 2020 | $104,000 | – | 3,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |